Biological Modulation of Solid Tumours by Interferons

  • Karl Pummer
Conference proceedings

Part of the ESO Monographs book series (ESO MONOGRAPHS)

Table of contents

  1. Front Matter
    Pages i-vii
  2. K. Pummer
    Pages 1-2
  3. M. Alvarez-Mon, J. Keller, L. Molto, L. Manzano, E. Reyes, M. Rodriguez-Zapata et al.
    Pages 3-12
  4. H. Stöger, H. Samonigg
    Pages 13-25
  5. G. Parmiani, A. Mazzocchi
    Pages 27-35
  6. H. Bier, W. Bergler
    Pages 37-44
  7. J. M. Ferrero, M. Namer
    Pages 45-51
  8. P. A. Ruffini, C. Gambacorti-Passerini
    Pages 53-60
  9. K. Pummer, P. Pürstner, G. Lanzer, U. Pätzold, H. L. Auner
    Pages 61-75

About these proceedings


In the 1960s, it was reported that interferons have antitumour activity in different experimental models. Since that time, numerous studies have been performed to elucidate the various mechanisms of action that have been proposed. However, there is much controversy in the literature and promising preclinical findings failed to translate into substantial clinical progress. The present book gives a critical overview of current knowledge of how interferons act in solid tumours. For this purpose, after two chapters of general aspects of interferon action and interaction, selected solid tumours which are commonly considered difficult to treat in advanced stages are discussed with respect to both preclinical data and clinical experience.


Biological therapy Solid Tumour breast cancer cancer carcinoma cell head and neck cancer interferon malignant melanoma melanoma prostate cancer renal cell carcinoma tumor

Editors and affiliations

  • Karl Pummer
    • 1
  1. 1.Universitätsklinik für UrologieGrazAustria

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1994
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-78868-0
  • Online ISBN 978-3-642-78866-6
  • Buy this book on publisher's site